Catalog No.
Product Name
Application
Product Information
Citations
-
Adenosine Analog
5’-O-(4,4’-Dimethoxytrityl)-2’-O-(2-methoxyethyl) adenosine is an adenosine analog that primarily targets adenosine receptors. This compound demonstrates biological activities such as smooth muscle vasodilation and potential inhibition of cancer progression. It is valuable for research in cardiovascular studies and cancer biology, facilitating investigations into adenosine signaling and therapeutic applications. -
Purine Nucleoside Analog
2'-Amino-2'-deoxy-5-methylcytidine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its primary mechanism involves the inhibition of DNA synthesis and the induction of apoptosis in cancer cells. This compound is valuable for research applications focused on understanding cancer biology and the development of novel therapeutic strategies. -
Purine Nucleoside Analog
1-Amino-3’-deoxy-7,8-dihydro-8-oxoguanosine is a purine nucleoside analog that primarily targets nucleic acid synthesis. This compound exhibits significant antitumor activity, particularly against indolent lymphoid malignancies, through mechanisms such as the inhibition of DNA synthesis and the induction of apoptosis. It is a valuable reagent for researchers investigating the therapeutic potential of nucleoside analogs in cancer treatment. -
Purine Nucleoside Analog
2'-β-C-Methyl-5-methoxyuridine is a purine nucleoside analog with significant antitumor activity. It primarily targets indolent lymphoid malignancies, exerting its effects through the inhibition of DNA synthesis and the induction of apoptosis. This compound is valuable for research applications focused on cancer biology and therapeutic development. -
Purine Nucleoside Analog
5,6-Dihydro-ara-uridine is a purine nucleoside analog known for its broad antitumor activity, particularly against indolent lymphoid malignancies. This compound primarily exerts its anticancer effects through the inhibition of DNA synthesis and the induction of apoptosis. It serves as a valuable research tool in the study of cancer therapeutics and cellular mechanisms related to purine metabolism. -
Purine Nucleoside Analog
2-Amino-6-chloro-9-(2-β-C-methyl-β-D-ribofuranosyl)-9H-purine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its primary mechanisms of action involve the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool in cancer research. This compound is utilized for exploring therapeutic strategies in oncology and can aid in the development of novel treatments for hematological cancers. -
Purine Nucleoside Analog
8-Aza-7-bromo-7-deazaguanosine is a purine nucleoside analog that effectively targets DNA synthesis pathways. It exhibits significant antitumor activity, particularly in the context of indolent lymphoid malignancies, by inducing apoptosis and disrupting cellular proliferation. This compound is valuable for researchers investigating mechanisms of cancer treatment and the role of nucleoside analogs in therapeutic applications. -
Purine Nucleoside Analog
2’-Deoxy-2’-fluoro-4-thio-beta-D-arabinouridine is a purine nucleoside analogue that exhibits significant anticancer properties. This compound primarily targets and inhibits DNA synthesis, leading to the induction of apoptosis in cancer cells. It is particularly relevant for research on indolent lymphoid malignancies, offering insights into potential therapeutic strategies for various types of cancer. -
Purine Nucleoside Analog
3-Deoxy-1,2-O-isopropylidene-5-p-toluoyl-a-D-glycero-pent-3-enofuranose is a purine nucleoside analog that interferes with DNA synthesis in cancer cells. This compound exhibits significant antitumor activity, particularly against indolent lymphoid malignancies, by inducing apoptosis and disrupting cellular proliferation. It serves as a valuable tool for research focused on cancer biology and therapeutic development. -
Tryptamine Product
N-Hydroxyl-tryptamine is a tryptamine derivative synthesized through the action of flavin monooxygenase (FMO). This compound serves as a pivotal intermediate in the biosynthesis of various biologically active molecules. It is utilized in research applications focusing on neurochemistry, pharmacology, and the elucidation of serotonin-related pathways. -
Nucleoside Metabolite
5-Phospho-β-D-ribosylamine is a nucleoside metabolite that serves as an intermediate in the biosynthesis of purine nucleotides. It plays a pivotal role in diverse biological processes, including nucleotide metabolism and intracellular signaling pathways. This compound is useful in biochemical studies investigating purine metabolism, gene regulation, and cellular responses to nucleotide availability. -
Metabolite of Octadecenoic Acid
9-Hydroxy-12-oxo-15(Z)-octadecenoic acid is a metabolite of octadecenoic acid, functioning primarily within lipid metabolism pathways. This compound plays a role in elucidating the biological activities of free fatty acids and their derivatives. It is useful in research applications focused on metabolic regulation, lipid biochemistry, and cellular signaling mechanisms. -
Purine Nucleoside Analog
5-(N-Isopentenyl-N-trifluoroacetyl) aminomethyluridine is a purine nucleoside analogue that exhibits significant anticancer activity. Its primary mechanism involves the inhibition of DNA synthesis and the induction of apoptosis, making it particularly effective against indolent lymphoid malignancies. This compound is valuable for research applications focused on cancer biology and therapeutic development. -
Purine Nucleoside Analog
5'-Deoxy-5'-iodo-2'-O-methyluridine is a purine nucleoside analog that plays a vital role in cancer research. It exhibits broad antitumor activity, particularly against indolent lymphoid malignancies, through mechanisms such as the inhibition of DNA synthesis and the induction of apoptosis. This reagent is valuable for studies aimed at understanding the biochemical pathways involved in tumorigenesis and therapeutic resistance. -
Uridine Analog
7'-O-DMT-morpholino uracil is a uridine analog that targets various biological processes associated with RNA synthesis. It exhibits potential antiepileptic properties and serves as a valuable tool for investigating anticonvulsant and anxiolytic activities. Additionally, this compound can be utilized in the development of novel antihypertensive agents, making it suitable for a range of biomedical research applications. -
Purine Nucleoside Analog
3’-Deoxy-N1-methyladenosine is a purine nucleoside analog that exhibits broad antitumor activity, particularly against indolent lymphoid malignancies. Its primary mechanisms of action include the inhibition of DNA synthesis and the induction of apoptosis. This compound is valuable for research applications focused on cancer therapeutics and understanding the cellular mechanisms underlying malignancies. -
Purine Nucleoside Analog
2-Amino-7-propargyl-7,8-dihydro-8-oxo-9-(beta-D-3-deoxy-ribofuranosyl)purine is a purine nucleoside analog known for its broad antitumor activity, particularly against indolent lymphoid malignancies. Its anticancer mechanisms involve the inhibition of DNA synthesis and the induction of apoptosis. Additionally, this compound serves as a versatile click chemistry reagent, featuring an alkyne group that enables copper-catalyzed azide-alkyne cycloaddition (CuAAc) with azide-containing molecules, making it useful in diverse chemical biology applications. -
Phosphinothricin Precursor
Fosfomycin trometamol impurity 49, also known as AcDMPt, is an N-acetylated precursor of phosphinothricin (Pt). This compound is a valuable intermediate in the synthesis of phosphinothricin, which is relevant in studies of herbicide action and antibiotic development. Its unique structure allows for exploration of biochemical pathways and mechanisms associated with phosphinothricin activity. -
Purine Nucleoside Analog
N1-Methyl-2’-deoxyinosine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. This compound primarily functions by inhibiting DNA synthesis and inducing apoptotic pathways in cancer cells. Its role as a nucleoside analog makes it an important tool for research in oncology and the development of novel therapeutic strategies. -
Purine Nucleoside Analog
7-Allyl-7,8-dihydro-8-oxo-9-(β-D-xylofuranosyl) guanine is a purine nucleoside analog that exhibits significant antitumor activity against indolent lymphoid malignancies. This compound primarily acts by inhibiting DNA synthesis and inducing apoptosis in targeted cells. Its application in cancer research underscores its potential as a therapeutic agent in the treatment of specific malignancies. -
Purine Nucleoside Analog
6-(1-Piperazinyl)-9-β-D-ribofuranosyl-9H-purine is a purine nucleoside analog that exerts significant anticancer effects. This compound primarily inhibits DNA synthesis and promotes apoptosis, making it effective against indolent lymphoid malignancies. It serves as a valuable tool in cancer research and the development of therapeutic strategies targeting lymphoid cancers. -
Purine Nucleoside Analog
4’-Methylthymidine is a purine nucleoside analog with significant antitumor activity, particularly effective against indolent lymphoid malignancies. Its primary mechanism involves the inhibition of DNA synthesis, leading to the induction of apoptosis in cancer cells. This compound serves as a valuable tool in cancer research and therapeutic development, aiding in the exploration of treatment strategies for lymphoid malignancies. -
Cell Cytotoxic Agent
Rabacfosadine succinate is a prodrug of the nucleotide analogue PMEG, functioning primarily as a cell cytotoxic agent. It exhibits selective cytotoxicity towards lymphoid cells, making it a valuable tool for studying lymphocyte-mediated processes and cancer biology. This compound is relevant in research applications focused on lymphoproliferative disorders and targeted cancer therapies. -
Adenosine Analog
N6-Methyl-xylo-adenosine is an adenosine analog that primarily targets adenosine receptors. This compound exhibits smooth muscle vasodilatory effects and has demonstrated potential in inhibiting cancer progression. Its unique properties make it a valuable tool for researchers investigating vascular biology and cancer therapies. -
Nucleoside Metabolite
UDP-α-sulfoquinovose is a nucleoside metabolite that serves as an essential precursor in the sulfolipid biosynthesis pathway. This compound plays a critical role in the formation of sulfolipids, which are important components of plant membranes and involved in various biological processes. UDP-α-sulfoquinovose is utilized in research focused on plant biology, lipid metabolism, and cell membrane studies. -
Purine Nucleoside Analog
3’-Deoxy-3’-α-C-methyladenosine is a purine nucleoside analog that exhibits significant antitumor activity, specifically against indolent lymphoid malignancies. Its primary mechanism involves the inhibition of DNA synthesis and the induction of apoptosis in cancer cells. This compound serves as a valuable tool in cancer research and therapeutic development, aiding in the exploration of novel treatments for lymphoid malignancies. -
Nucleoside Metabolite
N-Formimino-L-aspartate is a nucleoside metabolite known for its role in the metabolism of purines and pyrimidines. It is involved in various biochemical pathways and can be utilized in research applications focused on cellular metabolism and nucleotide synthesis. Investigations utilizing N-Formimino-L-aspartate may provide insights into metabolic disorders and the regulation of nucleotide levels in biological systems. -
Purine Nucleoside Analog
5’-O-Acetyl-2’,3’-dideoxy-2’,3’-didehydro-uridine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its mechanisms of action include the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool for cancer research. This compound can be utilized in studies aimed at understanding and developing therapeutic strategies for lymphoid malignancies. -
Cytidine Analog
1-[3’-O-[(4,4’-Dimethoxytriphenyl)methyl]-a-L-threofuranosyl]-N4-benzoylcytosine is a cytidine analog that functions primarily by inhibiting DNA methyltransferases. This compound exhibits notable anti-metabolic and anti-tumor properties, making it a valuable tool in cancer research. Its role in modulating DNA methylation patterns can provide insights into epigenetic mechanisms and therapeutic strategies in oncology. -
Guanosine Analog
2′-Deoxy-N-(2-furanylmethyl)guanosine is a guanosine analog that targets immune modulation through Toll-like receptor 7 (TLR7) activation. It exhibits immunostimulatory properties and has been shown to induce type I interferons in certain animal models, leading to antiviral effects. This compound serves as a valuable tool for research into antiviral therapies and immune response mechanisms. -
Purine Nucleoside Analog
N6-Benzoyl-5'-O-(4,4'-dimethoxytrityl)-3'-O-(2-methoxyethyl)adenosine is a purine nucleoside analog that exhibits significant antitumor activity against indolent lymphoid malignancies. This compound primarily functions by inhibiting DNA synthesis and inducing apoptosis, making it a valuable tool for cancer research. Its unique structure enhances its potential applications in the development of targeted therapies for various malignancies. -
Nucleoside Metabolite
(2S)-2-Isopropyl-3-oxosuccinate is a nucleoside metabolite known for its role in various biochemical pathways. This compound demonstrates significant activity in metabolic studies and is utilized in research focused on nucleoside metabolism and related enzymatic processes. Its application is valuable in exploring cellular energy dynamics and the regulation of metabolic pathways in both physiological and pathological conditions. -
Purine Nucleoside Analog
7-Propargyl-7,8-dihydro-8-oxo-9-(β-D-xylofuranosyl)guanine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its anticancer mechanisms involve the inhibition of DNA synthesis and the induction of apoptosis. Additionally, this compound serves as a click chemistry reagent, featuring an alkyne group that enables copper-catalyzed azide-alkyne cycloaddition (CuAAc) with azide-containing molecules, thereby facilitating various biochemical applications in research. -
Purine Nucleoside Analog
2’-Fluoro-2’-deoxy-N6-methylarabinoadenosine is a purine nucleoside analog that primarily targets DNA synthesis. This compound exhibits broad antitumor activity, particularly against indolent lymphoid malignancies, through mechanisms such as the inhibition of DNA synthesis and the induction of apoptosis. Its application in research contributes to the understanding of cancer biology and the development of therapeutic strategies for lymphoid malignancies. -
Norovirus Inhibitor
CMX-521 is a nucleoside analog that functions as a potent inhibitor of the RNA-dependent RNA polymerase (RdRp) of norovirus. This compound effectively suppresses both murine norovirus (MNV) and human norovirus, making it a valuable tool for research into norovirus infections. Its inhibitory properties are essential for studies focused on antiviral development and mechanisms of norovirus replication. -
Purine Nucleoside Analog
2-Amino-6-methylthio-9-(β-D-ribofuranosyl)-9H-purine is a purine nucleoside analog that exerts its biological activity primarily through the inhibition of DNA synthesis. This compound demonstrates significant antitumor activity against indolent lymphoid malignancies, making it a valuable tool for cancer research. Its mechanisms may involve the induction of apoptosis, providing insight into therapeutic strategies targeting neoplastic diseases. -
Antiangiogenic Agent
Antiangiogenic agent 2 is a potent inhibitor of thymidine phosphorylase, exhibiting an IC50 of 39.71 μM. This compound demonstrates significant anti-angiogenic activity, making it a valuable tool for research focused on cancer biology and therapeutics targeting tumor vasculature. It can be utilized in studies aimed at understanding angiogenesis and developing novel anti-cancer strategies. -
Thymidine Analog
2’,3’,5’-Tri-O-acetyl-5,N3-dimethyluridine is a thymidine analog known for its incorporation into replicated DNA. As a nucleotide substitute, it can facilitate studies in DNA synthesis and cellular labeling. This compound is useful in research applications that require tracking of nucleic acid dynamics and the analysis of replication processes. -
Purine Nucleoside Analog
5-Aza-3'-deoxycytidine is a purine nucleoside analog that exhibits potent antitumor activity, particularly against indolent lymphoid malignancies. Its primary mechanisms include the inhibition of DNA synthesis and the induction of apoptosis, making it an important tool in cancer research. This compound is widely utilized for investigating therapeutic strategies and mechanisms underlying hematological cancers. -
Purine Nucleoside Analog
2’-O-Methyl-N1-methyladenosine is a purine nucleoside analog that targets cellular processes associated with nucleotide synthesis. This compound exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its mechanism of action includes the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable reagent for cancer research applications. -
Purine Nucleoside Analog
1-(β-D-Xylofuranosyl)-2-thiouracil is a purine nucleoside analog known for its broad antitumor activity, particularly against indolent lymphoid malignancies. Its anticancer mechanisms primarily involve the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool for cancer research. This compound is useful in studies exploring the efficacy of nucleoside analogs in therapeutic strategies. -
Thymidine Analog
3’-β-C-Ethynyl-5-methyl uridine is a thymidine analog known for its insertional activity in replicated DNA. This compound serves as a valuable tool for cellular labeling and monitoring of DNA synthesis. Additionally, it contains an alkyne group, enabling it to participate in copper-catalyzed azide-alkyne cycloaddition (CuAAC), making it a versatile reagent in click chemistry applications. -
Purine Nucleoside Analog
Arabinosylisocytosine is a purine nucleoside analog that exhibits broad antitumor activity, particularly effective against indolent lymphoid malignancies. Its primary mechanisms of action include inhibition of DNA synthesis and induction of apoptosis, making it a valuable tool for cancer research. This compound can be utilized in studies focusing on the cellular responses to nucleoside analogs and their therapeutic potential in treating various malignancies. -
Purine Nucleoside Analog
2-Methylamino-N6-methyladenosine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its anticancer mechanisms include the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool for research in cancer therapeutics. This compound is essential for studying the biological effects of purine analogs in oncology applications. -
Nucleoside Analog
2'-Deoxy-2'-fluoroguanosine-5'-triphosphate (2'-F-dGTP) is a nucleoside analog that serves as a key monomer for nucleic acid synthesis. It exhibits unique properties that enable its incorporation into RNA and DNA, altering their stability and functionality. This compound is particularly valuable in studies involving molecular biology, genetic engineering, and the development of antiviral therapies. -
Purine Nucleoside Analog
5-Iodo-2'-β-C-methyl cytidine is a purine nucleoside analogue that exerts its biological effects by inhibiting DNA synthesis. This compound demonstrates significant antitumor activity, particularly against indolent lymphoid malignancies, by promoting apoptosis and disrupting cellular proliferation. It serves as a valuable tool for research applications focused on cancer biology and therapeutic strategies. -
Purine Nucleoside Analog
1-Amino-7,8-dihydro-8-oxo-9-(β-D-xylofuranosyl) guanine is a purine nucleoside analog that primarily acts on DNA synthesis pathways. Characterized by its broad antitumor activity, this compound is particularly effective against indolent lymphoid malignancies. Its anticancer mechanisms involve the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable reagent for cancer research. -
Thymidine Analog
5’-(4,4’-Dimethoxytrityl)-5-methyluridine is a thymidine analog that exhibits insertional activity within replicated DNA. This compound is instrumental in labeling cells, facilitating the tracking of DNA synthesis, and studying nucleic acid processes. Its unique properties make it a valuable tool for molecular biology research and applications involving DNA manipulation. -
Purine Nucleoside Analog
6-(4-Morpholinyl)-9-β-D-ribofuranosyl-9H-purine is a purine nucleoside analog with significant antitumor activity. It effectively targets indolent lymphoid malignancies through mechanisms that include the inhibition of DNA synthesis and the induction of apoptosis. This compound is valuable in cancer research, particularly in studying therapies aimed at lymphoid malignancies. -
Oligonucleotide
m7GpppUmpG is an oligonucleotide and an M7GpppNpG trinucleotide cap analogue. It serves as a valuable chemical tool for the synthesis of RNA containing either cap 0 or cap 1 structures. This compound is instrumental in studies involving RNA capping mechanisms and can be utilized in various RNA-based research applications, including gene expression and RNA stability investigations.
